In response to infection, antigen-specific CD8 + T cells are primed in the T cell zone of secondary lymphoid organs and differentiate into effector cytotoxic T cells (T C cells) to eliminate infected cells 1 . Concurrently, CD4 + T cells differentiate into follicular helper T cells (T FH cells) that localize to B cell follicles and promote protective antibody responses 2 . During unresolved infections, however, some viruses escape immune control and persist in cells; for example, human immunodeficiency virus (HIV) and Epstein-Barr virus (EBV) persist in T FH cells and B cells, respectively [3] [4] [5] [6] [7] [8] . Consequently, T FH cells are largely responsible for the production of replication-competent and infectious HIV in aviremic HIV-infected people treated with antiretroviral therapy (ART) and thus the persistent infection in these cells represents a major obstacle in the pursuit of a functional cure for HIV infection 8 . Understanding of the differentiation of T C cells and their localization in B cell follicles is therefore needed for the design of new strategies to eradicate infected cells in follicles for a permanent cure.
The coordinated differentiation of distinct effector populations of T C cells is required for the efficient elimination of infected or cancerous cells. During acute infection, naive antigen-specific CD8 + T cells differentiate not only into effector cells but also into memory precursor cells. After resolution of the infection, the majority of these cells undergo apoptosis, whereas a small fraction of the cells give rise to mature memory cells 9, 10 . During unresolved infections or cancer, however, antigenspecific T C cells undergo a different differentiation program that results in a state referred to as T cell 'exhaustion' , which is characterized by the upregulation of multiple inhibitory receptors, including PD-1, loss of effector function and clonal deletion, as well as the impaired generation of memory T cells 11 . However, it has become evident that even under conditions of chronic stimulation of T cells with antigens, some cells retain their proliferative ability and can be used to reinvigorate the T C cell response 12 .
and CD4 + T cells can differentiate into the T H 1 subset of helper T cells that upregulate expression of the chemokine receptor CXCR3 to migrate to inflamed tissues. Alternatively, antigen-stimulated CD4 + T cells migrate to the T cell-B cell border, where they can upregulate CXCR5 expression and differentiate into T FH cells that enter B cell follicles 18, 19 . Although it is clear that CD8 + T cells utilize CXCR3 in a similar fashion 1, 15 , surprisingly little is known about the ability of T C cells to enter B cell follicles and control infection at this site. Although some studies have suggested that T C cells are excluded from entry into B cell follicles 20, 21 , one study has demonstrated CXCR5 + CCR7 -T C cells in the B cell follicles of human tonsils 22 .
Here we found that CXCR5 + CCR7 -antigen-specific T C cells developed in response to viral infection in mice and humans. These cells, which we have called 'follicular cytotoxic T cells' (T FC cells), migrated to B cell follicles, where they eradicated virus-infected T FH cells and B cells. Transcriptional profiling and phenotyping of antigen-specific T FC revealed that T FC cells shared many characteristics with T FH cells and had some similarity to memory T C cells. The transcription factors Blimp1 and E2A directly regulated Cxcr5 expression and, together
The differentiation of T C cells is driven by a network of transcriptional regulators, most prominently by T-bet, Blimp1 and Id2. Other transcriptional regulators, including Eomes, Bcl6, TCF-1 and Id3, are known to coordinate the differentiation of memory T cells 9, 10 . Some of the transcription factors that control the coordinate differentiation of effector and memory T cells, including T-bet, Blimp1 and Eomes, also control exhaustion during chronic infection [12] [13] [14] , which suggests that different transcriptional modules fulfill context-specific roles.
In addition to the acquisition of cytotoxic effector function, migration to the site of infection or tumor growth is a prerequisite for the efficient function of T C cells. The entry of T C cells into lymphoid and non-lymphoid tissues is well studied 1 . Many chemokine receptors, integrins and other molecules that control T cell migration have been found to regulate the positioning of T cells during the immune response and in the memory phase 1, 15, 16 . This has been particularly well studied for helper T cell subsets that differ strikingly in their migratory abilities 17 . Naive T cells express the chemokine receptor CCR7 and localize to the T cell zone. Upon antigen stimulation, such as during viral infection, CCR7 expression is downregulated cells during HIV infection. There were few T C cells in the B cell follicles of lymph nodes from HIV -people, but the number of such cells was much greater in untreated HIV-infected people (Fig. 1a) . In contrast, the number of T C cells in the T cell zone was similar in these two groups (Fig. 1a) . Notably, some follicular T C cells localized in close proximity to HIV-infected cells (Fig. 1b) , which suggested they might have a role in controlling the infection in B cell follicles. The localization of CD4 + T cells to B cell follicles is facilitated by CXCR5 expression 18 . We hypothesized that a similar mechanism might also govern the follicular positioning of T C cells during infection. Indeed, we identified CXCR5 expression in a substantial frequency of CD45RA -CCR7 -effector T C cells in lymph nodes from HIV-infected people (Fig. 1c) .
To investigate how T C cells gain access to B cell follicles during viral infection, we made use of the DOCILE strain of LCMV, which causes chronic infection in mice and shares some characteristics with HIV, in the context of infection 23 . We also used CD8 + T cells from P14 mice, which have transgenic expression of a T cell antigen receptor (TCR) with Bcl6, TCF-1 and the E2A-inhibitory proteins Id2 and Id3, formed a transcriptional circuit that guided T FC cell development. Although T FC cells were especially abundant during chronic infection, such as infection with lymphocytic choriomeningitis virus (LCMV) in mice or with HIV in humans, they were also detectable during acute infection or after immunization. Furthermore, CXCR5 + T FC cells were present in mice with nascent B cell lymphoma, which suggested that these cells might also contribute to the immunosurveillance of B cell lymphoma. Overall, our data indicated that the differentiation of T FC cells was a common feature of CD8 + T cell responses that allowed the control of pathogen-infected or malignant cells in B cell follicles and might also contribute to the development of memory T C cells. npg ing infection, CXCR5 was expressed on a subset of mouse and human T C cells and was required for their migration into B cell follicles.
RESULTS

T FC cells express CXCR5 to localize to B cell follicles
T FC cells control viral infection of T FH cells
We next sought to determine the function of T FC cells. LCMV clone 13 has been shown to 'preferentially' replicate in myeloid cells but also infects CD4 + T cells 26 . We observed a similar infection pattern for LCMV DOCILE (data not shown). Intracellular staining with an antibody (VL4) specific to LCMV nucleoprotein can be used to quantify viral particles in cells 26, 27 . LCMV-infected mice had a substantial number of virusinfected CD4 + T cells (Supplementary Fig. 2a ). In addition, we observed LCMV infection in both T FH cells in B cell follicles and non-T FH cells in T cell zones (Fig. 2a) . At day 15 after infection, T FH cells showed higher infection rates than those of non-T FH cells (Fig. 2b,c) , a result confirmed by quantification of LCMV RNA (Supplementary Fig. 2b ).
To determine whether T FC cells specifically controlled the infection of T FH cells, we adoptively transferred SMARTA CD4 + T cells (which have transgenic expression of a TCR specific for the LCMV epitope of glycoprotein amino acids 66-77) 28 together with either Cxcr5 +/+ P14 cells or Cxcr5 -/-P14 cells into host mice and infected the recipients with LCMV DOCILE (Supplementary Fig. 3a ). To avoid competition with endogenous T cells, we used OT-I mice carrying an irrelevant TCRencoding transgene as recipients in these experiments. As expected, after infection of the host mice with LCMV DOCILE, SMARTA cells differentiated into both T FH cells and non-T FH cells (Fig. 2d) . At day 10 after infection, the differentiation of T FH cells, population expansion of P14 cells and viral loads in serum and spleen were similar in mice that specific for the LCMV epitope of glycoprotein amino acids 33-41 (gp33) 24 . We transferred congenically marked P14 CD8 + T cells into wild-type mice before infecting the recipients with LCMV DOCILE. On day 8 after infection, P14 cells were present not only in the T cell zone but also in B cell follicles, where they persisted beyond day 21 after infection ( Fig. 1d) . We also observed endogenous CD8 + T cells in B cell follicles in LCMV-DOCILE-infected mice that did not receive P14 cells (Supplementary Fig. 1a ). Both the transferred P14 cells and the endogenous activated T C cells showed minimal expression of CCR7 (Supplementary Fig. 1b ). CXCR5 expression was detected on approximately 20% of the P14 cells and 10% of the endogenous LCMV-specific CD8 + T cells ( Fig. 1e and Supplementary Fig. 1c ). The frequency of the CXCR5 + subset among the transferred P14 cells increased from day 8 to day 15 and remained high at least until day 35 after infection ( Fig. 1f) . Upregulation of CXCR5 expression was also detected on OT-I CD8 + T cells (which have transgenic expression of a TCR specific for the ovalbumin (OVA) epitope of amino acids 257-264) 25 in mice infected with OVA-expressing influenza virus or immunized with OVA in complete Freund's adjuvant ( Supplementary Fig. 1d ,e). To test our hypothesis that CXCR5 mediates the migration of T FC cells into B cell follicles, we transferred CXCR5-sufficient (Cxcr5 +/+ ) P14 cells or CXCR5-deficient (Cxcr5 -/-) P14 cells individually into recipient wildtype mice that we subsequently infected with LCMV DOCILE, then compared the localization of the donor cells. Notably, Cxcr5 -/-P14 cells were severely impaired in their ability to enter B cell follicles relative to that of their Cxcr5 +/+ counterparts, although they localized normally to the T cell zone (Fig. 1g) . In summary, these data demonstrated that dur- 
npg
As in the mouse model of B cell infection, CXCR5 expression was also detected on human T C cells specific for EBV (also known as human herpesvirus 4) in tonsils from people previously infected with EBV ( Fig. 3c) . Finally, large numbers of CXCR5 + T FC cells were detected in B cell lymphoma-bearing mice but not in healthy control mice (Fig. 3d) . Together these data demonstrated that T FC cells controlled the viral infection of B cells and suggested that they might also contribute to the immunosurveillance of nascent B cell lymphoma.
T FC cells are phenotypically and transcriptionally distinct
To characterize T FC cells comprehensively at the molecular level, we performed RNA sequencing for transcriptional profiling of CXCR5 + T FC cells and CXCR5 -non-T FC P14 cells sorted from mice at day 8 after infection with LCMV DOCILE. Although both populations shared many molecular characteristics and differed profoundly from their naive counterparts, we found 1,201 transcripts that were significantly (P < 0.05) upregulated or downregulated (twofold or more) in T FC cells relative to their expression in non-T FC cells and thus made up the T FC cell transcriptional signature ( Fig. 4a and Supplementary  Fig. 5 ). T FC cells had lower expression of transcripts encoding effector molecules involved in cytotoxicity, including granzymes A and B, perforin and IFN-g, and had higher expression of genes encoding products involved in the development of memory T cells, including IL-7R and CD62L (encoded by Sell). Furthermore, T FC cells had higher expression of transcripts encoding ICOS, Ly108 (Slamf6) and CD200 but lower expression of those encoding SLAM (Slamf1) (Fig. 4a) . Havcr2 and Cd244 (which encode the inhibitory receptors Tim-3 and 2B4, respectively) had lower expression in T FC cells than in non-T FC cells, although Pdcd1 (which encodes PD-1) had similar expression in these cells (Fig. 4a) . We confirmed differential expression of many of these molecules at the protein level (Fig. 4b-f) . Notably, T FC cells had received Cxcr5 +/+ P14 cells and those that had received Cxcr5 -/-P14 cells ( Supplementary Fig. 3b-e) . Furthermore, the number of non-T FH cells infected with LCMV was similar in the two groups (Fig. 2e) . In contrast, the frequency of LCMV-infected T FH cells in mice that had received Cxcr5 -/-P14 cells was about twofold higher than that in mice that had received Cxcr5 +/+ P14 cells (Fig. 2e) . In particular, infected T FH cells with large amounts of LCMV were at least threefold more abundant in mice that had received Cxcr5 -/-P14 cells than in mice that had received Cxcr5 +/+ P14 cells (Fig. 2e) . Therefore, the lack of T FC cells resulted in a selective increase in the infection of T FH cells. Overall, these data indicated a specific role for CXCR5 + T FC cells in controlling the infection of T FH cells. 3 and the development of B cell lymphoma 29 . Consistent with that, we observed pronounced accumulation of CXCR5 + T FC cells in mice infected with the B cell-tropic herpesvirus MuHV-4 (murid herpesvirus 4) (Fig. 3a) . At day 15 after infection, more than 15% of total CD8 + T cells expressed CXCR5 (Fig. 3a) . The anatomical localization of T FC cells suggested that they would also be able to control infected B cells. To test that idea, we adoptively transferred either Cxcr5 +/+ CD8 + T cells or Cxcr5 -/-CD8 + T cells into recipient OT-I mice, which we subsequently infected with MuHV-4 expressing enhanced green fluorescent protein (GFP) from an intergenic EF1a promoter to visualize infected cells 30 . At day 9 after infection, the population expansion and activation of the transferred Cxcr5 +/+ T C cells was similar to that of their Cxcr5 -/-counterparts ( Supplementary Fig. 4a,b) . However, the frequency of MuHV-4-infected B cells was about 4.5-fold higher in mice that had received Cxcr5 -/-T C cells than in mice that had received Cxcr5 +/+ T C cells (Fig. 3b) . npg and resulted in their increased recruitment to B cell follicles (Fig. 6b) .
CXCR5 + T FC cells in B cell infection and malignancy CD8 + T cells have a prominent role in controlling the infection of B cells by herpesviruses
A R T I C L E S
Overexpression of Bcl6 was sufficient to recapitulate the T FC cell phenotype, including upregulation of the expression of IL-7R, CD62L and ICOS, downregulation of the expression of granzyme B and Tim-3, and reduced cytotoxic activity, relative to that of control cells transduced with empty vector (Supplementary Fig. 7b-d) . Furthermore, overexpression of Bcl6 enhanced the expression of Tcf7 (which encodes TCF-1) and Id3 but inhibited the expression of Prdm1 (which encodes Blimp1) and Id2 (Supplementary Fig. 7e ). We next transferred control P14 T cells (expressing loxP-flanked Bcl6 alleles (Bcl6 fl/fl )) or Bcl6-deficient P14 T cells (with deletion of Bcl6 fl/fl alleles by Cre recombinase expressed from the T cell-specific gene Cd4 (Bcl6 fl/fl Cd4 Cre )) into congenically marked wild-type recipient mice, which we then infected with LCMV DOCILE and assessed at day 8 after infection. Consistent with the proposal of a critical role for Bcl6 in T FC cell differentiation, the Bcl6-deficient P14 cells failed to differentiate into T FC cells (Fig. 6c) . Blimp1 has been shown to antagonize T FH cell differentiation 32 . To assess the possibility of a negative regulatory function for Blimp1 in T FC cell differentiation, we reconstituted lethally irradiated host mice with bone marrow cells from control mice (Prdm1 fl/fl ) or mice with T cell-specific deletion of Prdm1 fl/fl alleles (and thus Blimp1) by Cre recombinase expressed from the T cell-specific gene Lck (Prdm1 fl/fl Lck Cre ), mixed at a ratio of 1:1 with congenically marked wild-type bone marrow cells. After reconstitution, we infected the chimeras with LCMV DOCILE and assessed them at day 15 after infection. We found that LCMV-specific Blimp1-deficient T C cells positive for the H-2D b -gp33 tetramer had much higher CXCR5 expression than that of their Blimp1-sufficient counterparts (Fig. 6d) . Consistent with the proposal of an important role for Blimp1 in T FC differentiation, Blimp1-deficient Tc cells displayed significant deregulation of genes in the T FC cell transcriptional signature (20.2% upregulated and 25.3% downregulated) relative to the expression of these genes in their Blimp1-sufficient counterparts 40 ( Supplementary  Fig. 8a ). During T FH cell development, TCF-1 promotes Bcl6 expression and inhibits Blimp1 expression [36] [37] [38] 41 . To assess the possibility of a similar role for TCF-1 in T FC cells, we generated bone marrow chimeras that contained a mixture of wild-type T cells and control (Tcf7 fl/fl ) T cells or TCF-1-deficient (Tcf7 fl/fl Lck Cre ) T cells, infected the chimeras with LCMV DOCILE and assessed them at day 15 after infection. We found that LCMV-specific H-2D b -gp33 + T C cells lacking TCF-1 were severely impaired in the generation of T FC cells relative to that of their TCF-1-sufficient counterparts (Fig. 6e) . In summary, Bcl6, supported by TCF-1, was necessary and sufficient to direct the differentiation of T FC cells, whereas Blimp1 repressed their development.
Id2 and Id3 dampen CXCR5 expression and T FC differentiation
Id2 and Id3 are transcriptional regulators that sequester transcription factors of the E-protein family, including E2A, and inhibit CXCR5 did not express ICOSL, a marker for CD8 + regulatory T cells in B cell follicles that have been identified in certain models for autoimmune diseases 31 (Supplementary Fig. 6a ), or IL-21, the helper cytokine produced by T FH cells to support antibody responses 2 ( Supplementary  Fig. 6b ). CXCR5 + T FC P14 cells executed cytotoxic function, although, consistent with their lower expression of some cytotoxic molecules, they were less efficient than their CXCR5 -counterparts ( Fig. 4g and  Supplementary Fig. 6c) . Overall, these data indicated that T FC cells constituted a distinct effector T C cell subset that differed phenotypically, transcriptionally and functionally from conventional effector T C cells.
T FC differentiation is controlled by the Bcl6-Blimp1 axis
To begin to understand the molecular requirements for T FC cell differentiation, we assessed the expression of key transcriptional regulators in LCMV-specific T C cells from wild-type mice or transgenic mice in which GFP was used to report the expression of Blimp1, Id2 or Id3, all infected with LCMV DOCILE. T FC cells from both wild-type mice and reporter mice had significantly larger amounts of Bcl6, TCF-1 and Id3 (Fig. 5a ) but smaller amounts of Blimp1 and Id2 (Fig. 5b) than those of non-T FC cells. Notably, this transcription-regulator-expression profile was similar to that of T FH cells [32] [33] [34] [35] [36] [37] [38] [39] . Indeed, we found striking enrichment for the transcriptional signature of T FC cells in the gene-expression signature associated with T FH cells, with 67.7% of the upregulated genes and 92.2% of the downregulated genes in T FC cells being regulated correspondingly in T FH cells (Supplementary Fig. 7a ).
Bcl6 has a key role in T FH cell biology and is sufficient to drive T FH cell development [32] [33] [34] . Consistent with that, overexpression of Bcl6 substantially increased the proportion of CXCR5-expressing P14 cells from ~20% to ~60% in mice infected with LCMV DOCILE (Fig. 6a) Blimp1 and E2A regulate the T FC cell transcriptional network Consistent with the finding of a critical function for Bcl6 in T FC cell differentiation, we found enrichment for genes bound by Bcl6 among the genes expressed differentially in T FC cells (Supplementary Fig. 8d ). However, consistent with published results 44, 45 , there was no evidence for direct regulation of CXCR5 expression by Bcl6 (data not shown). In contrast, analysis of genes bound by Blimp1 in T C cells and by E2A in thymocytes, by chromatin immunoprecipitation followed by deep sequencing (ChIP-seq), identified two Blimp1-binding sites and one E2A-binding site at the Cxcr5 locus (Fig. 8a) that contained the consensus Blimp1-binding motif and E2A-binding motif, respectively (Fig. 8b) .
In vivo reporter assays with retroviral vectors 38 that contained wildtype or mutated Blimp1-binding motifs (Fig. 8b,c) revealed that Blimp1 mediated suppression of Cxcr5 promoter activity and that this suppression was abolished when the binding sequence was mutated (Fig. 8d) .
In contrast, binding of E2A promoted Cxcr5-promoter-driven transcription; however, this activity was largely eliminated in the presence of the adjacent Blimp1-binding site (Fig. 8e) . We also observed binding of Blimp1 and E2A at the Tcf7, Bcl6 and Id3 loci as well as binding of E2A at expression in thymocytes and peripheral CD4 + T cells 35, 39 . We observed that Id3 was expressed selectively in CXCR5 + T FC P14 cells, whereas Id2 had high expression in CXCR5 -non-T FC P14 cells (Fig. 5) .
To investigate the possibility of a role for Id2-mediated repression of Cxcr5, we generated bone marrow chimeras containing a mixture of wild-type T cells and control (Id2 fl/fl ) or Id2-deficient (Id2 fl/fl Lck Cre ) T cells. We found that after infection of the chimeras with LCMV DOCILE, loss of Id2 promoted T cell-intrinsic CXCR5 expression on LCMV-specific H-2D b -gp33 + T C cells (Fig. 7a) . Similarly, in bone marrow chimeras mice containing a mixture of wild-type T cells and Id3-deficient T cells (with a transgene encoding GFP knocked into the Id3 locus, which leads to disruption of Id3 expression 35 (Id3 GFP/GFP )) or control (Id3 +/+ ) T cells and infected with LCMV DOCILE, loss of Id3 promoted T FC cell development, as judged by the significantly higher expression of CXCR5 on LCMV-specific H-2D b -gp33 + T C cells than on wild-type cells (Fig. 7b) . In line with those results, P14 cells that overexpressed Id3 gave rise to significantly fewer T FC cells when transferred into mice that were infected with LCMV DOCILE (Fig. 7b,c) . Consistent with the proposal of a critical role for Id2 or Id3 in inhibiting the generation of T FC cells, Id2-or Id3-deficient T cells 42, 43 showed significant deregulation of T FC transcriptional signature genes (Supplementary Fig. 8b,c) . Therefore, limiting Blimp1 and E2A and mediated the control of Cxcr5 transcription. E2A activated Cxcr5 transcription, whereas Blimp1 was a potent repressor of this process. Notably, we found that Id3, which was expressed specifically in T FC cells, was critical in 'titrating' E-protein activity. Deletion of Id3 resulted in increased CXCR5 expression, whereas its overexpression resulted in potent repression of CXCR5 expression. Id2 appeared to fulfil a similar function in conventional T C cells, which would suggest that tight control of CXCR5 expression is critical for the coordinated development of an effective CD8 + T cell response. As Blimp1 and E2A have been shown to regulate CXCR5 expression in T FH cells and B cells 32, 46, 47 , this transcriptional module might represent a common molecular mechanism that determines not only CXCR5 expression but also the functional diversification of multiple cell types. Interestingly, our data not only showed functional specialization of CXCR5-expressing T C cells that supported their classification as T FC cells but also demonstrated that CXCR5 expression marked a subpopulation of T C cells during chronic infection with a less-exhausted phenotype. In line with that notion, CXCR5 + T C cells displayed lower expression of the inhibitory receptors Tim3 and 2B4 than that of conventional T C cells, although their PD-1 expression was unchanged relative to that of conventional T C cells. However, this seemed to be a consequence of high Bcl6 expression and seemed to be independent of the relative expression of T-bet or Eomes, which have been shown to determine the development of CD8 + cells that are terminally exhausted or retain replicative capacity, respectively 12 . Consistent with the idea that T FC cells during chronic infection constitute a less-exhausted effector T cell population that retains memory T cell potential, T FC cells were characterized by higher expression of molecules linked to memory development, such as CD62L, IL-7R and TCF-1, and correspondingly showed lower expression of effector molecules, including granzymes and perforin, relative to that of conventional T C cells. This expression profile could be explained at least in part by the lower expression of Blimp1, which is required for the expression of multiple cytotoxic molecules 40, 48, 49 . Blimp1 is also a potent repressor of the memory differentiation program and a direct negative regulator of Sell (which encodes CD62L), Il7r and Tcf7 (refs 40,48-50) . Thus, T FC cell differentiation came at a cost: upregulation of Bcl6 and downregulation of Blimp1 not only led to CXCR5 expression to promote the entry of T C cells into B cell follicles but also led to a reduction in effector cytotoxic function, which in turn rendered the viral control exercised by T FC cells less efficient.
Persistence of virus in infected cells, in particular in T FH cells, is one of the main obstacles to the elimination of HIV infection in people on ART. Studies of humans infected with HIV and monkeys infected with simian immunodeficiency virus, all being treated with ART, suggest that insufthe Id2 locus (Supplementary Fig. 8e ), which suggested central roles for both factors (Blimp1 and E2A) in the transcriptional network that regulated T FC cell development. In line with that, we found significant enrichment (P = 0.001) for E2A-or Blimp1-bound genes among the T FC cell signature genes, and more than 50% of the genes bound by Blimp1 or E2A were expressed differentially in T FC cells relative to their expression in non-T FC cells (Supplementary Fig. 8f,g) . Consistent with the proposal of an important function for TCF-1, we also found significant enrichment for genes bound by TCF-1 among the genes expressed differentially in T FC cells (Supplementary Fig. 8h ). In conclusion, our data indicated that Bcl6, Blimp1, TCF-1 and E2A (with its regulators Id3 and Id2) formed a transcriptional circuit that controlled the expression of CXCR5 and directed the differentiation of T FC cells. DISCUSSION CD8 + T cells have been detected in the B cells follicles of human tonsils 22 , but their function has remained elusive. Using both human subjects and mouse models, we have described here a previously unreported population of effector T C cells, T FC cells, which specifically expressed CXCR5 and localized to B cell follicles. Our data have revealed a hitherto unappreciated role for CXCR5 + T FC cells in the control of infection in B cell follicles. The lack of CXCR5 + T FC cells resulted in exaggerated infection in B cell follicles, specifically in T FH cells in the LCMV model and B cells in the muHV-4 model. Intriguingly, we also observed the generation of T FC cells in a model of B cell lymphoma, a phenomenon tightly linked to published data demonstrating a critical role for CD8 + T cells in the control of B cell lymphoma 29 . Thus, to our knowledge, our study is the first to define T FC cells and elucidate their function in detail.
CXCR5 is usually not expressed on CD8 + T cells, but it is required for the migration of T FC cells into B cell follicles. Accordingly, we found that the Cxcr5 transcription was tightly regulated during T C cell differentiation. We identified three conserved regulatory elements in the 5´ region and intron 1 of Cxcr5 that were bound by the transcription factors forming assay). Viral PFU in tested samples were extrapolated using the standard curve. To ensure that values fell within the linear range of the standard curve, sera were diluted at 1:100 and spleens were weighed and homogenized at 100 mg/ml.
Flow cytometry.
The list of all antibodies used for flow cytometry is in Supplementary Table 2 . Mouse splenocytes were stained with Fc-receptor blocking antibodies (clone 2.4G2, 1:100 dilution, BD) for 10 min on ice to block non-specific staining. Primary anti-mouse antibodies were then added and incubated for 1 h at 4 °C, followed by 30 min of PECy5.5-streptavidin (Thermofisher, SA1018) staining on ice. Staining for CCR7 was done at 37 °C for 20 min. To detect endogeneous gp33 specific T C , APC-conjugated H-2D b -gp33-tetramer (MBL, TS-M512-P) was used to stain mouse splenocytes, and CXCR5-PEdazzle594 was used instead of CXCR5-biotin and PECy5.5-streptavidin. For staining of intracellular cytokines, whole splenocytes were stimulated with 5 mg/mL of gp33 peptide in the presence of monensin and brefeldin A (eBioscience, 00-4506 and 00-4505) for 4 h at 37 °C. Stimulated cells were then subject to the same antibody-staining protocol as above. For staining of human cells, primary anti-human antibodies were incubated for 30 min at 25 °C. To detect EBV-specific tonsillar T C cells, according to their HLA class I type, tonsillar UMs were stained with primary antibodies and either HLA-A*0201 tetramers carrying YVLDHLIVV (YVL) or GLCTLVAML (GLC) peptides (derived from EBV antigens BRLF1 and BMLF1 respectively), or HLA-B*0801 tetramer carrying RAKFKQLL (RAK) peptide (BZLF1), as previously described 59 .
For intracellular staining, cells were washed twice after surface staining and permeabilized using Cytofix/Cytoperm (BD, 554722) for 30 min on ice. Antibodies specific for intracellular proteins were diluted in Perm/Wash Buffer (BD, 554723) and incubated for 30 min at 25 °C. For intranuclear staining, cells were permeabilized using Transcription Factor Staining Buffer Set (eBioscience, 00-5523-00) for 30 min on ice. Antibodies specific for intranuclear proteins were diluted in Permeabilization Buffer (eBioscience, 00-8333) and incubated for 60 min at 25 °C, followed by secondary antibody staining on ice.
To exclude dead cells, cells were stained with 7-AAD (Thermofisher, A1310). To exclude dead cells from staining protocols that involved permeabilization, cells were stained with Zombie Aqua Fixable Viability Kit (Biolegend, 423101) before permeabilization.
For flow cytometry of mouse studies, T C and T H cells were gated on CD8 + TCRb + B220 -and CD4 + TCRb + B220 -, respectively. For flow cytometry of LN from HIV-infected patients, T C cells were gated on CD8 + TCRab + CD19 -. All samples were subsequently analyzed using BD LSR II flow cytometer. Detail and validation profiles of antibodies are in Supplementary Table 2 . Antibodies of the same or overlapping fluorophores were used separately.
Immunofluorescence. The list of all antibodies used for Immunofluorescence is in Supplementary Table 2. Immunofluorescence analysis was performed either alone or after RNAscope in situ hybridization as previously described 21, 34, 60 . For mouse spleen tissues, middle section of spleens were cut and submerged in optimal cutting temperature (OCT) compound and stored at -80 °C. Human LNs were processed in similar fashion. OCT block were then sectioned at 6-7µm thickness and fixed with acetone for 10 min at -20 °C. Sections were blocked with Fc-receptor-blocking antibody (clone 2.4G2, 1:100, BD), followed by staining with primary antibodies. Sections were washed and stain with secondary antibodies or AF555-streptavidin (1:200, Thermofisher, S32355). All steps were performed at 25 °C for 60 min in the dark. Slides were washed and incubated with 0.1% Sudan Black B in 70% ethanol (Cat. No.4410; ENG Scientific) followed by TBS for 30 min at 25 °C to quench autofluorescence. Sections were counterstained with DAPI and mounted using Fluoromount G (ProSciTech) or Prolong Gold (Invitrogen). Mouse sections were visualized using an Olympus Provis AX70 Widefield fluorescence microscope. Human LN sections were visualized using Olympus FV10i confocal microscope using a 60x phase contrast oil-immersion objective (NA 1.35) imaging. Quantification of Tc was performed by visually counting cells per area of section. Details and validation profiles of antibodies are in Supplementary Table 2. Retroviral vector-mediated gene overexpression. GFP bicistronic retroviral vector containing Bcl6 has been described 32 . mCherry bicistronic retroviral vector containing Id3 was generated by cloning Id3 into the vector. Thy1.1 reporter constructs were kindly provided by Lilin Ye 36 . Cloning of cassettes were performed as previously described 36 . Retroviruses were then generated by transfecting the plasmids into a retrovirus-packaging cell line GPE86. GFP or mCherry positive GPE86 were sorted to isolate stably transfected cells. Stably transfected GPE86 were then cultured in cDMEM for 48 h and retrovirus in the culture supernatant were collected for the transduction of primary CD8 + T cells. To prepare primary CD8 + T cells for transduction, naive CD8 + T cells were purified from P14 mice and stimulated with plate-bound anti-CD3 and anti-CD28 (Supplementary Table 2 ) for 48 h. For the transduction, cells were spinoculated at 800 g for 1 h at 32 °C. Cells were rested in fresh cRPMI media containing 20 ng/mL of rmIL7. After 48 h, GFP + or mCherry + P14 were sorted and 6,000 sorted cells were transferred into congenically marked WT mouse. 24 h later, mice were infected with LCMV (DOCILE). For the study of Bcl6 overexpression on transcriptional regulation of other genes, cells were rested in 10 ng/mL of IL-2 and 100 ng/mL of IL-12 for 48 h, GFP + cells were then sorted and subjected to Q-PCR analysis as described above.
Ex vivo cytotoxic assay. The ex vivo cytotoxic assay was adapted from a previous study 61 . CD44 -CD62L + CXCR5 -(naive) P14 cells were sorted from P14 mice and transferred into congenically marked WT host, followed by infection with Docile. 8 days after infection, splenocytes were isolated and sorted for CD44 + CD62L -CXCR5 -(CXCR5 -non-T FC ) and CD44 + CD62L -CXCR5 + (CXCR5 + T FC ) P14 cells. These cells were used as effector cells (E). To prepare target cells, splenocytes were isolated from uninfected WT mice and stained with 20 mM or 1 mM of cell trace violet (CTV) dye (Invitrogen). 20 mM-stained (CTV hi ) splenocytes were incubated with gp33 peptide (KAVYNFATM) at 10 mg/mL for 1 h at 37 °C in cRPMI media. 1 mM-stained splenocytes (CTV lo ) were incubated with cRPMI media alone. Cells were then washed extensively, counted, mixed at 1:1 ratio and used as target cells (T). To prepare T FH and non-T FH target cells, SMARTA cells were injected into congenic WT mice and infected with DOCILE. D8 after infection, in vivo differentiated T FH and non-T FH SMARTA cells were sorted and stain with CTV as above. Effector cells and target cells were then mixed at 4:1 E:T ratio in U-bottom 96-well and cultured for 10 h in cRPMI at 37 °C. Cells were then stained with 7-AAD to exclude dead cells and analyzed with flow cytometry. % specific cytotoxicity was calculated as follows:
Effector cytotoxicity (A) = (%CTV hi /%CTV lo ) Target only cytotoxicity (B) = (%CTV hi /%CTV lo ) % specific cytotoxicity = (1-A/B) × 100 For ex vivo cytotoxicity of Bcl6-overexpressed P14 cells, transduced cells were restimulated with plate-bound anti-CD3/CD28 for 24 h. GFP + cells were sorted and used as effector cells in the ex vivo cytotoxicity assay as described above.
RNA sequencing. CD44 -CD62L + CXCR5 -naive CD8 + T cells were purified from P14 mice and transferred into congenically marked WT mice. RNA was also extracted from purified naive P14 cells. 24 h after adoptive transfer, mice were then infected with LCMV (DOCILE). 8 days after infection, splenocytes were collected and sorted for CD44 + CXCR5 -(CXCR5 -non-T FC ) and CD44 + CXCR5 + (CXCR5 + T FC ) P14 cells, followed by RNA extraction using the RNAeasy Micro Kit (Qiagen). RNA integrity was analyzed using Agilent RNA 6000 Nano Kit (Agilent). PolyA-enrichment was used for library preparation and 50 bp oneend sequencing was performed by Monash Health Translation Precinct Medical Genomics Facility. Transcriptional profiling of Blimp1-deficient CD8 + T cells was described earlier 40. ChIP sequencing. E2A Bio-ChIP-seq was performed with total thymocytes from Tcf3 Bio/Bio Rosa26 BirA/BirA mice. The precipitated genomic DNA was amplified with the KAPA Real Time Amplification kit (KAPA Biosystems). Cluster generation and sequencing was carried out using the Illumina HiSeq 2000 system with a read length of 50 nucleotides according to the manufacturer's guidelines.
To analyze ChIP-seq data, Bowtie2.2.8 has been used for alignment with mouse mm9 as reference genome, MACS2.1.0 for peak calling with a P value of 10 -10 as cutoff. The peak table with the peak starting and ending location was mapped to genes with the following strategies: Peaks were assigned to genes in a stepwise manner by prioritizing genes containing peaks in their promoter and/or gene body. For this, peaks with -2.5 kb to TSS and +2.5 kb to TES were first assigned to the corresponding gene. Other peaks within 50 kb to gene body were assigned to the nearest gene for long distance regulation. R functions Venn in g-plots groups. Two-way ANOVA was used to calculate multivariate data set. Repeatedmeasure (RM) two-way ANOVA was used to calculate paired multivariate samples. ANOVA analysis was corrected by Sidak's multiple comparison tests. Wilcoxon matched-pairs rank test was to calculate paired samples between two groups. Animals were of matched sex and age, no randomization were performed for the grouping of animals. Blinding was not performed due to the objective measurement of the experimental data. All statistical analysis were performed using Prism GraphPad.
